Tom Gibbs joined OptiNose in September 2016 as Chief Commercial Officer. In this role, Mr. Gibbs has responsibility for all activities associated with the commercial function of the company and has executive oversight of business development. Mr. Gibbs brings more than 20 years of diverse commercial leadership experience to OptiNose, including roles in general management, marketing, sales, commercial operations, customer insights, analytics, and finance. He joined OptiNose from Takeda Pharmaceuticals, where he led the General Medicines Business Unit for the United States. In this role, Gibbs had responsibility for a multi-billion dollar portfolio comprised of 11 brands spanning several therapeutic classes including CNS, GI, inflammation, diabetes, and metabolics, and led a team of over 2,000 people. Before joining Takeda, Mr. Gibbs was at Vanda Pharmaceuticals, where he was the Chief Commercial Officer for the US and EU commercial organizations, including the rare disease franchise and CNS portfolio. Prior to joining Vanda, Mr. Gibbs spent more than five years at Bristol-Myers Squibb, where he held a variety of commercial leadership roles of increasing responsibility. Most recently, Mr. Gibbs served as the Vice President of Worldwide Commercial Operations, where he helped drive the transformation of the company’s commercial model and commercial organization across all therapeutic categories and geographies. Prior to working at Bristol-Myers Squibb, Mr. Gibbs was the Vice President of US Sales for Novartis Vaccines & Diagnostics, where he led the launch of two new vaccines, designed and deployed a pediatric sales force, developed and implemented a supply chain solution to support a direct distribution business model, and created a sales operations infrastructure to support an expanded sales force. Earlier in his career, Mr. Gibbs held multiple US and global marketing roles at SmithKline Beecham (now GSK), Johnson & Johnson, and Endo Pharmaceuticals. Tom holds a BS in economics with a dual concentration in finance and marketing and an MBA from the Wharton School of the University of Pennsylvania

business development,finance ,marketing